Revenue $2.18B, up 4.8% on a year earlier. Americas net sales $1.24B, up 5.6%. EMEA Net Sales $937.00M, up 3.7%. Diluted EPS $1.03 against $0.77.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $2.18B | $2.09B | $2.08B | +4.8% |
| Operating income | $326.10M | $373.20M | $300.00M | +8.7% |
| Net income | $198.30M | $238.30M | $153.40M | +29.3% |
| Diluted EPS | $1.03 | $1.22 | $0.77 | |
| Operating cash flow | $447.80M | $359.40M | $378.20M | +18.4% |
| Capital expenditures | -$54.20M | -$36.30M | -$50.10M | |
| Free cash flow | $393.60M | $323.10M | $328.10M | +20.0% |
| Dividend per share | $0.24 | $0.24 | $0.24 |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Americas net sales | $1.24B | $1.17B | +5.6% |
| EMEA Net Sales | $937.00M | $903.50M | +3.7% |
| Hips net sales | $562.70M | $536.10M | +5.0% |
| Knees net sales | $828.90M | $826.00M | +0.4% |
| Net sales growth | 4.8% | 6.97% | |
| S.E.T. net sales | $586.00M | $550.60M | +6.4% |
| Constant Currency Net Sales Growth | 4.7% | 5.4% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Zimmer Biomet Holdings (ZBH) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/ZBH/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
